Abstract:Head lice, Pediculis capitis De Geer, populations were investigated for permethrin and malathion resistance after initial establishment of a discriminating dose of topical application bioassay with body lice, Pediculus humanus L. For both insecticides, approximately 2 times the lethal dose (LD)95 at 4 h was selected, 2 ng of permethrin and 100 ng of malathion per head louse, respectively. Head lice were collected from heads of infested children in Denmark at 33 primary schools, one kindergarten, and seven boar… Show more
“…Clinical and parasitological resistance to head lice was first observed in1994 [16]. Since then, head lice resistance has been often documented [6, 9, 21, 22]. Strategies for treating resistant lice include yearly rotation of available pediculicides, retrying the initial agent at a higher concentration or for a longer application time, and switching to a different product [3].…”
“…Clinical and parasitological resistance to head lice was first observed in1994 [16]. Since then, head lice resistance has been often documented [6, 9, 21, 22]. Strategies for treating resistant lice include yearly rotation of available pediculicides, retrying the initial agent at a higher concentration or for a longer application time, and switching to a different product [3].…”
“…A study published in 2003 reported a resistant kdr-like allele frequency ranging from 0.33 to 1.00 in California, Florida, and Texas [11]. Other studies have also reported variable frequencies: 0.07 in Japan [30], 0.44 in Wales, UK [31], 0.93 in France [32], 0.95 in Denmark [17], and 0.97 in Canada [33]. Indeed, the widespread use of pyrethroids may have been a key factor in the selection of homozygous resistant lice.…”
Section: Pyrethroidsmentioning
confidence: 99%
“…Resistance to malathion was first reported in France [39], and then in the UK [2], Australia [25], and Denmark [17]. The effectiveness of malathion in a single-blind, randomized study in the UK was poor, showing cure rates of only 17% (n = 30) [9].…”
Insecticide treatment resistance is considered to be a major factor in the increasing number of infestations by head lice. The large insecticide selection pressure induced by conventional topical pediculicides has led to the emergence and spread of resistance in many parts of the world. Possible mechanisms of resistance include accelerated detoxification of insecticides by enzyme-mediated reduction, esterification, oxidation that may be overcome by synergistic agents such as piperonyl butoxide, alteration of the binding site, e.g. altered acetylcholinesterase or altered nerve voltage-gated sodium channel, and knockdown resistance (kdr). Clinical, parasitological and molecular data on resistance to conventional topical pediculicides show that treatments with neurotoxic insecticides have suffered considerable loss of activity worldwide. In particular, resistance to synthetic pyrethroids has become prominent, probably because of their extensive use. As other treatment options, including non-insecticidal pediculicides such as dimeticone, are now available, the use of older insecticides, such as lindane and carbaryl, should be minimized, owing to their loss of efficacy and safety concerns. The organophosphorus insecticide malathion remains effective, except in the UK, mostly in formulations that include terpineol.
“…Certainly, this is a factor contributing to the effect, partly because some people have become blasé about the efficacy of products, partly because they are trying to economize when faced with repeated need to treat, and partly through lack of skill. However, those same factors contributed to the development of acquired resistance to commonly used insecticides like permethrin and malathion and, when the warning signs of consumer dissatisfaction 25-30 years ago were not heeded, it resulted in complete loss of usefulness of the insecticides in most territories and regions within a little over a decade (Chosidow et al, 1994;Mumcuoglu et al, 1995;Rupeš et al, 1995;Burgess et al, 1995;Picollo et al, 1998;Pollack et al, 1999;Downs et al, 1999Downs et al, , 2002Hunter & Barker, 2003;Kristensen et al, 2006;Kasai et al, 2009).…”
Section: Discussionmentioning
confidence: 99%
“…Head lice with acquired resistance to pyrethroid insecticides were identified more or less concurrently by several investigators from different countries in the early 1990s (Chosidow et al, 1994;Mumcuoglu et al, 1995;Rupeš et al, 1995;Burgess et al, 1995). Subsequently resistance and resistance mechanisms were identified in widely distributed territories (Picollo et al, 1998;Pollack et al, 1999;Hunter & Barker, 2003;Kasai et al, 2009) and were also found to affect other insecticides in addition to the pyrethroids (Downs et al, 1999(Downs et al, , 2002Kristensen et al, 2006).…”
Treatment of head louse infestation has evolved from widespread use of neurotoxic insecticides that have been extensively affected by resistance since the mid-1990s into the use of so-called physically acting treatments. It is widely believed that physically acting products are effectively “resistance proofed” because they do not act to inhibit any particular physiological mechanism and most have some kind of occlusive effect on the target organism. Over the past 20 years various new active materials have been utilized ranging from natural oils, synthetic oils, through to surfactants both as excipients and active substances. Relatively few of these products have been adequately tested clinically and, of those that have, there is now some indication that they are less effective than when first introduced. The question therefore arises whether lice can become resistant to these physically acting products. Only adequate testing both in the laboratory and in clinical trials can determine their real effectiveness and claiming efficacy based on the presence of a named chemical rather than demonstrated activity may result in acquired resistance to these types of product also.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.